India's cheap weight-loss drugs could reshape global obesity fight
BBC News - World
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Continue reading on the source website
To respect copyrights, we only provide a brief summary. Read the full article on BBC News - World.
Read Full Article